Endometriosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032
Endometriosis is defined as the
abnormal growth of endometrial tissue, which is similar to that which lines the
interior of the uterus but occurs outside of the uterus. During menstruation,
endometrial tissue is shed. Endometrial implants are areas of endometrial
tissue found in ectopic sites. These lesions are most generally found on the
ovaries, the Fallopian Tubes, the uterine surface, the bowel, and the pelvic
cavity membrane lining (i.e., the peritoneum). They are less frequently found
in the vaginal, cervix, and bladder. Endometriosis can occur outside the pelvis
on rare occasions. While endometrial implants can cause complications, they are
usually harmless. Endometriosis is classified into four stages: I (mild), II
(mild), III (moderate), and IV (severe) based on the number, location, and
depth of implants, as well as the presence of filmy or dense adhesions. Another
staging system is based primarily on the company and severity of pelvic pain.
However, a more reliable staging method is being sought because intra-observer
and inter-observer variability are high in the staging systems.
- The prevalence of cases of Endometriosis ranges from 350 to
378 cases per 100,000 population in the USA.
Thelansis’s “Endometriosis Market
Outlook, Epidemiology, Competitive
Landscape, and Market Forecast Report – 2021 To 2032" covers disease
overview, epidemiology, drug utilization, prescription share analysis,
competitive landscape, clinical practice, regulatory landscape, patient share,
market uptake, market forecast, and key market insights under the potential Endometriosis
treatment modalities options for eight major markets (USA, Germany, France,
Italy, Spain, UK, Japan, and China).
KOLs insights
of Endometriosis across 8 MM market from the centre of Excellence/ Public/
Private hospitals participated in the study. Insights around current treatment
landscape, epidemiology, clinical characteristics, future treatment paradigm,
and Unmet needs.
Endometriosis Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment